Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
MOMA Therapeutics
MOMA Therapeutics
Kivu Bioscience Inc.
University of California, San Francisco
Evopoint Biosciences Inc.
Kestrel Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
Nammi Therapeutics Inc
National Cancer Institute (NCI)
Beijing Biotech
Jazz Pharmaceuticals
Revolution Medicines, Inc.
Bayer
National Institutes of Health Clinical Center (CC)
Unidade Local de Saúde São João
City of Hope Medical Center
Eli Lilly and Company
Institut Paoli-Calmettes
Filamon LTD
Eli Lilly and Company
AstraZeneca
NeoImmuneTech
University of Michigan Rogel Cancer Center
M.D. Anderson Cancer Center
Hoffmann-La Roche
Rutgers, The State University of New Jersey
National Institutes of Health Clinical Center (CC)
Psyence Australia Pty Ltd
ViroMissile, Inc.
Dana-Farber Cancer Institute
Sichuan Enray Pharmaceutical Sciences Company
Duke University
A2 Biotherapeutics Inc.
AstraZeneca
M.D. Anderson Cancer Center
Arvinas Inc.
Essen Biotech
National Institutes of Health Clinical Center (CC)
Azienda Ospedaliero-Universitaria di Parma
Dana-Farber Cancer Institute
Revolution Medicines, Inc.
Poseida Therapeutics, Inc.
MacroGenics
Unity Health Toronto
Daiichi Sankyo
SN BioScience
Cue Biopharma